Why the Market Dipped But Viking Therapeutics, Inc. (VKTX) Gained Today

The company's stock has dropped by 1.58% in the past month, falling short of the Medical sector's gain of 2.23% and the S&P 500's gain of 2.14%. Any recent changes to analyst estimates for Viking Therapeutics, Inc. should also be noted by investors. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook. The Zacks Rank system, spanning from #1 (Strong Buy) to #5 ...